|
|
||||||||
1 Institut National de la
Santé et de la Recherche Médicale U-127, Annexins are characterized by
Ca2+-dependent binding to
phospholipids. Annexin II mainly participates in cell-cell adhesion and
signal transduction, whereas annexins V and VI also seem to regulate
intracellular calcium cycling. Their abundance and localization were
determined in left ventricle (LV) and right ventricle (RV) from
hypertensive guinea pigs, during the transition from compensatory hypertrophy to heart failure. Immunoblot analysis of annexins II, V,
and VI revealed an increased accumulation (2.6-, 1.45-, and 2.3-fold,
respectively) in LV from hypertensive guinea pigs and no modification
in RV. Immunofluorescent labeling of annexins II, V, and VI; of
Na+-K+-ATPase;
and of sarcomeric
hypertrophy and heart failure; remodeling
THE ANNEXINS ARE A UNIQUE family of calcium binding
proteins characterized by calcium-dependent binding to phospholipids
(for a review, see Ref. 18). They contain a tetrarepeat of a conserved core domain (except annexin VI, which has an octarepeat) and therefore share important structural homologies (up to 80-90%). In
contrast, the NH2-terminal domain
is specific to each annexin and is involved in their functional
diversity. The different annexins have been shown to mediate a variety
of biological functions, such as exocytosis and endocytosis, membrane
trafficking, regulation of phospholipase A2 activity, and cell
differentiation (3, 5, 18, 19, 27). Annexin II has been mainly reported
to participate in signal transduction pathways and in membrane-fusion
events (28). In vitro studies have indicated that annexins V and VI
might be involved in the formation and regulation of calcium channels
(4, 15). In the heart, annexin II has been detected in rat (11) and
bovine (33) ventricular myocardium but not in atrial myocytes (10). Its
presence has been also reported in endothelial (31) and vascular smooth
muscle cells (21). Annexins V and VI are the major annexins in
mammalian heart (6, 16). However, their subcellular localization is
still controversial: annexin V has been shown to be absent from
myocytes and present in nonmyocyte cells (27) or localized in cardiac
myocytes (8, 11, 12, 16, 30) associated with cell membranes (8, 16) or
in association with the Z line of the cells (30). Annexin VI has been
mainly located in the sarcolemma and intercalated disks of cardiomyocytes (13). Although the functions of annexins within the
heart are unknown, their properties and abundance suggest that they
might play a role in hypertension and heart failure, particularly in
Ca2+-mediated events and cardiac
remodeling (23). In fact, it has been reported that the overexpression
of annexin VI in the heart of transgenic mice leads to cardiac
dilatation and altered calcium homeostasis (9). Furthermore, the
expression of annexin II was increased in vascular smooth muscle cells
by dexamethasone treatment, suggesting that it may be involved in the
elevated systemic vascular resistance observed in
glucocorticoid-induced hypertension (21). Moreover, Song et al. (22)
recently reported that the amount of annexins II and V was increased
whereas that of annexin VI was decreased in the human failing heart,
suggesting that annexins may be important in cardiac remodeling.
Knowing where a protein is expressed often provides a strong clue as to
its biological function; therefore we decided to determine the
localization of annexins II, V, and VI in guinea pig myocardium and to
investigate whether the cardiac levels and cellular localization of
annexins II, V, and VI were modified during the onset of cardiac failure in hypertensive animals. The guinea pig was chosen because calcium cycling in this species is similar to that in the human heart
(7, 24). Hypertension and left ventricular hypertrophy were induced by
suprarenal coarctation of the abdominal aorta, and the first signs of
heart failure were identified 20 mo later. Western blot analysis
indicated a large increase in the steady-state concentration of
annexins II, V, and VI in left ventricle (LV), and immunofluorescent
histochemistry strongly suggested that annexins are involved in
myocardial remodeling, particularly in fibrotic areas.
Animal model and tissues. Hypertension
and LV hypertrophy were induced in adult female guinea pigs (350 ± 50 g) from Charles River (Cléon, France) by stenosis of the
abdominal aorta above the renal artery (17). Sham-operated animals
underwent an identical procedure except that the hemoclip was not
placed around the aorta. All animal procedures were in accordance with
institutional guidelines and those formulated by the European Community
for use of experimental animals. Twenty months after surgery, animals
were anesthetized with successive intraperitoneal injections of
ketamine hydrochloride (20 mg/kg) followed by 2% xylazine (0.25 ml/kg)
10 min later. Hemodynamic parameters were measured in vivo in the
closed-chest anesthetized state. An ultraminiature catheter pressure
transducer was inserted into the right carotid artery and passed into
the LV. The catheter was attached to a transducer control unit (model TC50, Millar Instruments) connected to a recorder (2000 series, Gould
Electronic). Arterial pressures; left ventricular systolic, diastolic,
and end-diastolic pressures; and maximal rates of pressure development
were measured. At the end of recording period, hearts were excised,
weighed, and rapidly rinsed in ice-cold saline solution. Hearts from
operated animals were paired with those from sham-operated controls. An
equatorial section (5 mm) was cut for immunofluorescent histochemical
analysis. LVs with septum and right ventricles (RVs) were separated,
minced into 200- to 300-mg pieces, and frozen in liquid nitrogen.
Tissue samples were stored at Crude particulate preparation. Crude
particulate preparations (CPP) were obtained according to the method of
Rannou et al. (17). Briefly, tissue samples (200 mg) were thawed and
homogenized in 10 ml of buffer (200 mmol/l sucrose, 20 mmol/l HEPES, pH
7.4) containing protease inhibitors (1.1 µmol/l leupeptin, 0.7 µmol/l aprotinin, 120 µmol/l phenylmethylsulfonyl fluoride, 1 mmol/l iodoacetamide, 0.7 µmol/l pepstatin, 1 mmol/l
diisopropylfluorophosphate). The homogenate was centrifuged at 41,000 g for 45 min in a Sorvall SS34 rotor.
The pellet was suspended in 0.1 mol/l NaCl, 30 mmol/l imidazole, 8%
sucrose, pH 6.8, in the presence of the protease inhibitors. Protein
content was determined by the method of Lowry using bovine serum
albumin as a standard (12).
Western blot analysis. The amount of
annexin protein contained in CPP was assessed using the Western blot
technique (25). Anti-annexin antibodies were obtained by immunization
of a rabbit with recombinant human annexins. Anti-annexin II and V
antibodies did not cross-react with any other annexins. Anti-annexin VI
antibody was purified by immunoaffinity and was highly specific. Heart proteins from CPP (30 µg) were loaded on a 10% polyacrylamide SDS
gel. After electrophoretic separation, proteins were transferred to a
nitrocellulose sheet (Hybond ECL, Amersham) at 150 V for 1.5 h. The
membranes were then successively incubated in 5% fat-free milk, 0.1%
Tween
20 in PBS for 2 h at room temperature, specific antiserum in blocking
solution (1:5,000) overnight at 4°C, then with horseradish
peroxidase-conjugated anti-rabbit IgG for 2 h at room temperature. The
reactive proteins were detected by chemiluminescent reaction
(ECL+ kit, Amersham) followed by
exposition of the membranes to Hyperfilm ECL film and serial washes (5 × 5 min) with a medium composed of 0.1 M sodium acetate (pH = 4) and 0.5 M sodium chloride to eliminate the antibodies. The
proteins were then stained with Coomassie blue R250 (0.1% in 1%
CH3COOH, 40% methanol) for 5 min. Nonspecific staining was then suppressed by a 5-min wash in 10% CH3COOH, 50% methanol.
Quantification of both the specific bands on autoradiography and the
transferred MyHC band stained with Coomassie blue was performed by
densitometric analysis after scanning. Each individual value represents
the mean of three independent determinations.
Immunofluorescent histochemistry.
Cardiac samples were placed in mounting solution (Ystosystem) and
frozen at Statistical analysis. Results are
expressed as means ± SE. The statistical significance of
differences among the groups was determined by one-way ANOVA, and
comparisons between groups were performed by Scheffé's test. A
value of P < 0.05 was considered to
be statistically significant.
Anatomic and hemodynamic studies.
Abdominal aortic banding in 3-wk-old guinea pigs led to a progressive
increase in pressure overload, left ventricular hypertrophy, and
hypertension as the banded animals grew. Anatomic and hemodynamic data
for banded and sham-operated animals 20 mo after operation are
summarized in Table 1. By this time, guinea
pigs were adult animals and did not show any signs of senescence (life
duration is ~5 yr).
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
-actinin showed that in control LV and RV,
1) annexin II is present in
nonmuscle cells; 2) annexins V and
VI are mainly observed in the sarcolemma and intercalated disks of
myocytes; 3) annexins II, V, and VI
strongly label endothelial cells and adventitia of coronary arteries;
and 4) annexin VI is present in the
media. At the onset of heart failure, the most striking changes are the
increased protein accumulation in LV and the very strong labeling of
annexins II, V, and VI in interstitial tissue, suggesting a role in
fibrosis development and cardiac remodeling.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
80°C until use.
155°C in isopentane. Equatorial frozen sections
(7-8 µm) were fixed with acetone-methanol (1:1 for 20 min at
20°C), saturated with 5% BSA in PBS (30 min at room
temperature), incubated with mouse monoclonal anti-
-actinin antibodies (1:50 in PBS for 30 min at 37°C), washed, and incubated with appropriate dilutions of either anti-annexin II, anti-annexin V,
anti-annexin VI, or
anti-Na+-K+-ATPase
(2) antiserum (1:40, 1:20, 1:20, and 1:50, respectively, in PBS for 30 min at 37°C). After three rinses in PBS, the sections were
successively incubated for 30 min at room temperature with a 1:50
dilution of anti-mouse immunoglobulins conjugated with Texas red and a
1:50 dilution of anti-rabbit immunoglobulins conjugated with
fluorescein isothiocyanate fluorochrome. Fluorescence was visualized
using a Leitz DM RD microscope equipped with epifluorescence optics.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
Table 1.
Anatomic and hemodynamic parameters of sham-operated and banded guinea
pigs after 20 mo
The in vivo hemodynamic data show that aortic diastolic and systolic pressures were increased by 53 and 46%, respectively. LV systolic pressure was increased by 85% and LV diastolic pressure was unchanged. However, 20 mo after the operation an increase in LV end-diastolic pressure (34%) and a decrease in positive and negative dP/dt were observed. These changes were not observed at earlier time points (unpublished results). They represent the first signs of cardiac decompensation.
Body weight was not significantly different between the banded and sham-operated groups. Left ventricular weight and left ventricular-to-body weight ratio were significantly increased in banded animals, indicating LV hypertrophy, whereas right ventricular weight was not significantly different although a tendency toward an increase was observed. Moreover, lung and liver wet-to-dry weight ratios were unchanged in the banded animals (data not shown), demonstrating that there were no pathological features of established heart failure in this model.
Immunoblot analysis of annexin II, annexin V, and
annexin VI. Protein levels of annexin II, V and VI were
measured in CPP from sham-operated and banded animals with the
immunoblotting technique. As previously observed (17), the yield of
proteins in homogenate or CPP was similar in the two groups (71 ± 4.4 and 65.1 ± 4.2 mg protein/g of tissue in CPP,
respectively). An example of immunoblot analysis is shown in Fig.
1. The specific bands labeled with
anti-annexin antibodies correspond to 36 kDa for annexin II, 32.5 kDa
for annexin V, and 68 kDa for annexin VI. Increased amounts of annexins
were evident in LV from banded guinea pigs. Quantitative results
obtained after densitometric analysis of each band and normalization by
the protein content of each lane measured after Coomassie blue
staining are shown in Fig. 1B.
Significant increases in annexin II (2.6-fold), annexin V (1.45-fold),
and annexin VI (2.3-fold) levels were observed in LV of the banded
group. No significant modification of the accumulation of the annexins
was observed in RV of banded guinea pigs compared with sham-operated
guinea pigs.
|
Immunohistochemical localization of annexin II,
annexin V, and annexin VI. Double immunofluorescence
using annexin-specific polyclonal antibodies and
-actinin-specific
monoclonal antibody was employed to determine the myocyte or nonmyocyte
distribution of each annexin in the myocardium of sham-operated and
banded guinea pigs and to compare the annexin labeling to the striated pattern of sarcomeric filaments. In addition, sarcolemma and T tubules
were specifically labeled with
anti-Na+-K+-ATPase
antibodies (30).
In sham-operated animals, annexin II (Fig.
2A)
showed a striking preponderance in the capillaries and in the
endocardial endothelium, and immunoreactivity was faint in the
interstitial tissue between myocytes. In banded animals, distribution
of annexin II was unchanged, although labeling was reinforced between
myocytes (Fig. 2B). Double labeling
with
-actinin or phase-contrast imaging (not shown) demonstrated
that the most intense immunoreactivity corresponded to tissue areas
that were devoid of myocytes and might further represent fibrotic
areas. Annexin II localization in RV (Fig. 2C) from both sham-operated and
banded guinea pigs was similar to that of the LV from sham-operated
group.
|
Annexin V in LV (Fig. 3,
A and
C) and RV (not shown) from
sham-operated guinea pigs was mainly observed at the level of the sarcolemma and intercalated disks and penetrating into the myocytes. Immunofluorescence was also detected in striation parallel to the long
axis of the myocyte. The labeling of
Na+-K+-ATPase
(Figs. 3E and
4E), used as a marker of sarcolemma,
was detected as expected at the level of myocyte membranes and
invaginating into myocytes. In LV from banded animals, there was an
overall increase in the labeling of annexin V, particularly evident
between the myocytes (Fig. 3, B and
D), whereas there was no detectable change in RV (Fig. 3F).
|
As shown in Fig. 4, annexin VI was located
in the external sarcolemma and intercalated disks of myocytes from
sham-operated guinea pigs; a similar labeling was observed for the
Na+-K+-ATPase
(Fig. 4E). In LV (Fig. 4,
B and
D) and RV (Fig.
4F) from banded guinea pigs, the
localization was unchanged but the fluorescence was enhanced in LV.
|
Localization of annexins II, V, and VI in coronary arteries is
represented in Fig. 5. It shows that
annexins II and V were found in the endothelium and the adventitia of
large vessels. Immunoreactivity of annexin VI in coronary artery was
particularly intense in the endothelium and media. In banded animals,
the localization of annexins II, V, and VI was similar to that observed
in sham-operated guinea pigs.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study we examined the cardiac changes in steady-state concentration and cellular distribution of annexin II, annexin V, and annexin VI during the onset of cardiac failure. The findings demonstrate that the three annexins are expressed in guinea pig hearts and that their expression is highly increased in LV of banded animals whereas it is unchanged in RV. In sham-operated guinea pigs, annexin II is mainly localized in the membranes of nonmuscle cells whereas strong staining specific to annexins V and VI is observed in the sarcolemma and intercalated disks of myocytes. Interstitial tissue between myocytes shows strong immunoreactivity to all three annexins in the banded guinea pig hearts.
In this model of progressive overload induced by aortic stenosis in guinea pigs, we have previously shown that during compensatory hypertrophy, which is observed after 6 and 12 mo of aortic stenosis, left ventricular end-diastolic pressure and positive and negative dP/dt were similar in sham-operated and banded guinea pigs (unpublished results). The significant changes in these two parameters after 20 mo of aortic stenosis are indicative of the first signs of decompensatory hypertrophy and of the transition from compensatory hypertrophy toward heart failure.
The presence of annexins II, V, and VI in guinea pig hearts has been established by immunoblot analysis of crude particulate preparations obtained in the absence of Ca2+ chelating agents to prevent the loss of annexins in the cytosol. The result is in line with studies in other species (16). It also demonstrates the specificity of the antibodies used in the immunofluorescent histochemical analysis. At the onset of heart failure, the content of annexins II, V, and VI is largely increased whereas in human heart failure, only annexins II and V are increased (22). Whether the difference in annexin VI level is due to the species or to the severity of heart failure is unknown.
In this study, annexin II is localized to endothelial cells of the coronary arteries and intramyocardial capillaries, in agreement with the established presence of annexin II in vascular endothelium (14). It is undetectable in ventricular myocytes (Fig. 2) and in atrial myocytes (16). Annexin II in LV from banded guinea pigs is increased 2.6-fold. Immunofluorescence staining suggests that this increase is correlated to the presence of annexin II in the interstitial tissue, between myocytes (Fig. 2). The increased accumulation of annexin II is in agreement with the report of Song et al. (22) in heart failure, suggesting that it is maintained whatever the severity of heart failure. We suggest that, among the different properties of annexin II, its ability to bind to components of the extracellular matrix such as collagen (32) and to mediate cell-cell adhesion (3, 28) might be an important feature involved in the remodeling process of interstitial and perivascular fibrosis.
The localization of annexin V in mammalian myocardium is controversial.
As shown in Fig. 3, we found annexin V in the sarcolemma and in the
intercalated disks of myocytes, in agreement with other reports (6, 8,
16). Invaginations of the sarcolemma into the cells, similar to those
shown for the
Na+-K+-ATPase
(29), likely represent T tubules, as reported by Luckcuck et al. (13).
However, we did not find, as reported by Wang et al. (30) in isolated
cardiomyocytes from rat, that the labeling of annexin V is similar to
the striated pattern observed for
-actinin in guinea pig LV. Whether
this discrepancy is related to a difference between species or to the
specificity of the antibody for a splicing isoform of annexin V (30) is
undetermined. Furthermore, the faint longitudinal striation pattern
observed in longitudinal sections (Fig.
3B) strongly resembles that of
cardiotin, a sarcoplasmic reticulum-specific protein (20), suggesting
that annexin V is also present in sarcoplasmic reticulum. In LV from
banded guinea pigs, accumulation of annexin V is increased by 1.45-fold
and immunofluorescent analysis demonstrated that annexin V is mainly present in between the myocytes. Annexin V, like annexin II, is a
collagen-binding protein that might promote interactions between cells
and proteins of the extracellular matrix (32), suggesting a role for
annexin V in the development of fibrosis. Furthermore, in myocytes from
banded guinea pigs, the longitudinal pattern of annexin V labeling was
less prominent than in control myocytes and even absent in some areas.
If this is related to relocation of annexin V from sarcoplasmic
reticulum, it would suggest that in myocytes, annexin V might also
contribute to the alterations in
Ca2+ homeostasis and sarcoplasmic
reticulum Ca2+ handling reported
in hypertension and heart failure (1, 26).
Luckcuck et al. (13) reported a similar localization of annexins V and VI in transverse sections from porcine LV. In this study, we partly confirm these findings and found strong labeling of annexin VI in the sarcolemma and intercalated disks (Figs. 3 and 4) but we did not find annexin VI in T tubules. In LV from banded guinea pigs, the 2.3-fold increase in accumulation of annexin VI, the unchanged localization of annexin VI in myocytes, and the presence of annexin VI in interstitial tissue suggest that annexin VI, like annexins II and V, might be involved in the development of fibrotic areas. Moreover, it has been shown in transgenic mice that overexpression of annexin VI leads to dilated cardiomyopathy (9); this suggests that at the onset of heart failure, annexin VI may participate in the remodeling and altered properties of the myocardium.
In this study, we show that annexins II, V, and VI are present in coronary arteries (Fig. 5) and annexin II in capillary vessels. Endothelial cells are strongly labeled by the three annexins and media by annexin VI only. We do not find any obvious difference in the labeling of coronary arteries by annexins between LV from sham-operated and banded animals, but the very strong staining of annexins in both tissues argues for a role of annexins in vascular remodeling during hypertension.
In the present study, we have analyzed the expression and localization of annexins II, V, and VI in the hearts of hypertensive animals during the onset of heart failure and have shown, for the first time, that the accumulation of each annexin is increased in LV whereas it remains unchanged in RV. These results suggest a mechanical and not an hormonal regulation of their expression during hypertension. The present study also reports for the first time that the respective localizations of annexins II, V, and VI are modified in the diseased heart. In particular, a prominent labeling of annexins in the interstitial tissue is observed. According to the potential roles of annexins in the regulation of association between proteins of the extracellular matrix, we propose that they are involved in the myocardial and vascular remodeling process occurring during heart failure.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank L. Rappaport and C. Delcayre for helpful and constructive discussions, B. Prendergast for reviewing the English, and Matthieu Elgoyhen for technical help.
| |
FOOTNOTES |
|---|
This work was supported by grants from Association Française contre la Myopathie, from Fondation de France, from Institut National de la Santé et de la Recherche Médicale (PECO), and from Centre National de la Recherche Scientifique. I. Bélikova was supported by the Conseil Régional d'Ile de France.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. Charlemagne, INSERM U-127, IFR Circulation, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris Cedex 10, France (E-mail: d.charlemagne{at}inserm.lrb.ap-hop-paris.fr).
Received 13 March 1998; accepted in final form 15 December 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arai, M.,
H. Matsui,
and
M. Periasamy.
Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure.
Circ. Res.
74:
555-564,
1994
2.
Charlemagne, D.,
J. Orlowski,
P. Olivero,
F. Rannou,
C. Saint Beuve,
B. Swynghedauw,
and
L. K. Lane.
Alteration of Na,K-ATPase subunit mRNA and protein levels in hypertrophied rat ventricle.
J. Biol. Chem.
269:
1541-1547,
1994
3.
Creutz, C. E.
The annexins and exocytose.
Science
258:
924-931,
1992
4.
Diaz-Munoz, M.,
S. L. Hamilton,
M. A. Kaetzel,
P. Hazarika,
and
J. R. Dedman.
Modulation of Ca2+ release channel activity from sarcoplasmic reticulum by annexin VI (67-kDa calcimedin).
J. Biol. Chem.
265:
15894-15899,
1990
5.
Doubell, A. F.,
A. J. Bester,
and
G. Thibault.
Annexins V and VI: major calcium-dependent atrial secretory granule-binding proteins.
Hypertension
18:
648-656,
1991
6.
Doubell, A. F.,
C. Lazure,
C. Charbonneau,
and
G. Thibault.
Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart.
Cardiovasc. Res.
27:
1359-1367,
1993
7.
Fabiato, A.,
and
F. Fabiato.
Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and new-born rat ventricles.
Ann. NY Acad. Sci.
307:
491-522,
1978[Medline].
8.
Giambanco, I.,
G. Pula,
P. Ceccarelli,
R. Bianchi,
and
R. Donato.
Immunohistochemical localization of annexin V (CaBP33) in rat organs.
J. Histochem. Cytochem.
39:
1189-1198,
1991[Abstract].
9.
Gunteski-Hamblin, A. M.,
G. Song,
R. A. Walsh,
M. Frenzke,
G. P. Boivin,
G. W. Dorn,
M. A. Kaetzel,
N. D. Horseman,
and
J. R. Dedman.
Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1091-H1100,
1996
10.
Iida, H.,
T. Hatate,
and
Y. Shibata.
Immunocytochemical localization of 67 kD Ca2+-binding protein (p67) in ventricular, skeletal, and smooth muscle cells.
J. Histochem. Cytochem.
40:
1899-1907,
1992[Abstract].
11.
Jans, S. W. S.,
M. Van Bilsen,
C. P. M. Reutelingsperger,
M. Borgers,
Y. F. de Jong,
and
G. J. van der Vusse.
Annexin V in the adult rat heart: isolation, localization and quantitation.
J. Mol. Cell. Cardiol.
27:
335-348,
1995[Medline].
12.
Lowry, O. H.,
N. J. Rosenbrough,
A. Farr,
and
R. J. Randall.
Protein measurement with the folin phenol reagent.
J. Biol. Chem.
193:
265-275,
1951
13.
Luckcuck, T.,
C. H. Orchard,
S. M. Harrison,
and
J. H. Walker.
Subcellular localization of annexin V and VI in isolated rat ventricular myocytes and porcine left ventricle.
Biochem. Soc. Trans.
23:
28S,
1995[Medline].
14.
Nilius, B.,
V. Gerke,
J. Prenen,
G. Szûcs,
S. Heinke,
K. Weber,
and
G. Droogmans.
Annexin II modulates volume-activated chloride currents in vascular endothelial cells.
J. Biol. Chem.
271:
30631-30636,
1996
15.
Pollard, H. B.,
H. R. Guy,
N. Arispe,
M. Delafuente,
G. Lee,
E. M. Rojas,
J. R. Pollard,
M. Srivastava,
Z. Y. Zhang-Keck,
N. Merezhinskaya,
H. Caohuy,
A. L. Burns,
and
E. Rojas.
Calcium channel and membrane fusion activity of synexin and other members of the annexin gene family.
Biophys. J.
62:
15-18,
1992.
16.
Pula, G.,
R. Bianchi,
P. Ceccarelli,
I. Giambanco,
and
R. Donato.
Characterization of mammalian heart annexins with special reference to CaBP 33 (annexin V).
FEBS Lett.
277:
53-58,
1990[Medline].
17.
Rannou, F.,
C. Sainte-Beuve,
P. Oliviero,
E. Do,
P. Trouvé,
and
D. Charlemagne.
The effects of compensated cardiac hypertrophy on dihydropyridine and ryanodine receptors in rat, ferret and guinea-pig hearts.
J. Mol. Cell. Cardiol.
27:
1225-1234,
1995[Medline].
18.
Raynal, P.,
and
H. B. Pollard.
Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins.
Biochim. Biophys. Acta
1197:
63-93,
1994[Medline].
19.
Russo-Marie, F.
Annexins, phospholipase A2 and the glucocorticoids.
In: The Annexins, edited by S. E. Moss. London: Portland, 1992, p. 35-46.
20.
Schaart, G.,
L. Moens,
J. M. Endert,
and
F. C. S. Ramaekers.
Biochemical characterization of cardiotin, a sarcoplasmic reticulum associated protein.
FEBS Lett.
403:
168-172,
1997[Medline].
21.
Schelling, J. R.,
G. J. Gentry,
and
G. R. Dubyak.
Annexin II inhibition of G protein-regulated inositol trisphosphate formation in rat aortic smooth muscle.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F682-F690,
1996
22.
Song, G.,
B. Campos,
L. E. Wagoner,
J. R. Dedman,
and
R. A. Walsh.
Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure.
J. Mol. Cell. Cardiol.
30:
443-451,
1998[Medline].
23.
Song, G., D. L. Kirkpatrick, A. M. Gunteski-Hamblin, G. W. Dorn, J. R. Dedman, and
R. A. Walsh. Abnormal
Na+/Ca2+
exchanger activity in transgenic mice with cardiac specific
overexpression of annexin VI.
Circulation 92, Suppl.: I697-I698, 1995.
24.
Terraciano, C. M. N.,
and
K. T. MacLeod.
Measurements of Ca2+ entry and sarcoplasmic reticulum Ca2+ content during the cardiac cycle in guinea pig and rat ventricular myocytes.
Biophys. J.
72:
1319-1326,
1997
25.
Towbin, H.,
T. Staehelin,
and
J. Gordon.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:
4350-4354,
1979
26.
Turnay, J.,
J. K. Gwathmey,
and
J. P. Morgan.
Altered calcium handling in experimental pressure-overlaod hypertrophy in the ferret.
Circ. Res.
57:
836-843,
1985
27.
Van Bilsen, M.,
C. P. M. Reutelingsperger,
P. H. M. Willensem,
R. S. Reneman,
and
G. J. Van der gusse.
Annexins in cardiac tissue: cellular localization and effect on phospholipase activity.
Mol. Cell. Biochem.
116:
95-101,
1992[Medline].
28.
Waisman, D. M.
Annexin II tetramer: structure, and function.
Mol. Cell. Biochem.
149-150:
301-322,
1995.
29.
Wang, J.,
R. H. G. Schwinger,
K. Frank,
J. Müller-Ehmsen,
P. Martin-Vasallo,
T. A. Pressley,
A. Xiang,
E. Erdmann,
and
A. A. McDonough.
Regional expression of sodium pump subunit isoforms and Na+-Ca2+ exchanger in human heart.
J. Clin. Invest.
98:
1650-1658,
1996[Medline].
30.
Wang, L.,
M. M. Rahman,
H. Iida,
T. Inai,
S. Kawabata,
S. Iwanaga,
and
Y. Shibata.
Annexin V is localized in association with Z-line of rat cardiac myocytes.
Cardiovasc. Res.
30:
363-371,
1995[Medline].
31.
Wu, C. C.,
J. D. Croxtali,
M. Perretti,
C. E. Bryant,
C. Thiemermann,
R. J. Flower,
and
J. R. Vane.
Lipocortin I mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.
Proc. Natl. Acad. Sci. USA
92:
3473-3477,
1995
32.
Wu, L. N. Y.,
B. R. Genge,
G. C. Lloyd,
and
R. E. Wuthier.
Collagen-binding proteins in collagenase-released matrix vesicles from cartilage. Interaction betwen matrix vesicle proteins and different types of collagen.
J. Biol. Chem.
266:
1195-1203,
1991
33.
Zeng, F. Y.,
V. Gerke,
and
H. J. Gabius.
Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart.
Int. J. Biochem.
25:
1019-1027,
1993[Medline].
This article has been cited by other articles:
![]() |
V. Monceau, Y. Belikova, G. Kratassiouk, E. Robidel, F. Russo-Marie, and D. Charlemagne Myocyte apoptosis during acute myocardial infarction in rats is related to early sarcolemmal translocation of annexin A5 in border zone Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H965 - H971. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Chen, M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson Molecular responses of human muscle to eccentric exercise J Appl Physiol, December 1, 2003; 95(6): 2485 - 2494. [Abstract] [Full Text] |
||||
![]() |
V. Gerke and S. E. Moss Annexins: From Structure to Function Physiol Rev, April 1, 2002; 82(2): 331 - 371. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |